OLIO breast cancer trials are set to investigate innovative treatment options for young women diagnosed with hormone receptor-positive, HER2-negative breast cancer - the most common form of breast cancer. Despite the availability of effective treatments, breast cancer tends to recur more often in younger women, leading to poorer outcomes, and researchers are now working to…
